Search - tctmd.com

Displaying 241 - 260 of 314

Sort: Relevancy | Date

News Daily News

Meta-analysis Confirms Benefits of FFR-Guided Revascularization

Yael L. Maxwell

October 24, 2014

News Features

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

News Conference News TCT 2014

Marco Barbanti, MD, Receives Linnemeier Young Investigator Award

September 16, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Daily News

Las Sociedades Europeas Publican Directrices Actualizadas sobre Revascularización en el Manejo de EAC

L.A. McKeown

September 11, 2014

News Daily News

European Societies Release Updated Revascularization Guidelines for CAD

L.A. McKeown

September 11, 2014

News Conference News ESC 2014

Another Strike Against Thrombectomy in 1-Year TASTE Results

Todd Neale

September 02, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Daily News

Pre-AMI Ischemia May Reduce Early Mortality

July 24, 2014

News Daily News

Coronary Dominance Plays Role in Early Post-STEMI Mortality Risk

Yael L. Maxwell

June 24, 2014

News Industry News

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 21, 2014

News Industry News

Tryton Medical Announces Events at EuroPCR 2014 in Paris

May 12, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

News Daily News

Los Pacientes Ancianos con SCA Reciben Menos Tratamiento Intensivo siendo Menores los Beneficios sobre la Supervivencia

Caitlin E. Cox

March 27, 2014

News Daily News

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Caitlin E. Cox

March 27, 2014

News Daily News

High Sensitivity Troponin T Assay Shows Strong Prognostic Ability in STEMI Patients

L.A. McKeown

March 20, 2014

News Daily News

Thrombocytopenia Serves as Marker of Short- and Long-term Mortality after TAVR

L.A. McKeown

March 13, 2014

News Daily News

La Trombocitopenia Sirve como Marcador de la Mortalidad a Corto y Largo Plazo post-TAVR

L.A. McKeown

March 13, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

Advertisement

Meta-analysis Confirms Benefits of FFR-Guided Revascularization

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Marco Barbanti, MD, Receives Linnemeier Young Investigator Award

Keynote Address Focuses on Newer DES, Problematic Subgroups

Las Sociedades Europeas Publican Directrices Actualizadas sobre Revascularización en el Manejo de EAC

European Societies Release Updated Revascularization Guidelines for CAD

Another Strike Against Thrombectomy in 1-Year TASTE Results

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Pre-AMI Ischemia May Reduce Early Mortality

Coronary Dominance Plays Role in Early Post-STEMI Mortality Risk

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Tryton Medical Announces Events at EuroPCR 2014 in Paris

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

Los Pacientes Ancianos con SCA Reciben Menos Tratamiento Intensivo siendo Menores los Beneficios sobre la Supervivencia

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

High Sensitivity Troponin T Assay Shows Strong Prognostic Ability in STEMI Patients

Thrombocytopenia Serves as Marker of Short- and Long-term Mortality after TAVR

La Trombocitopenia Sirve como Marcador de la Mortalidad a Corto y Largo Plazo post-TAVR

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content